Praxis Precision Medicines, Inc. business relationships
Companies named in Praxis Precision Medicines, Inc.’s 10-K filed 2026-02-19, and public companies whose annual reports name Praxis Precision Medicines, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 5 / 100 Top 3% in its category
- Agent readiness
- 30 / 100
- AI adoption
- 0 / 100
Named in Praxis Precision Medicines, Inc.’s annual report 3
“Sublease, dated May 27, 2021, by and between CBRE, Inc. and Praxis Precision Medicines, Inc., as amended on September 23, 2025 and further supplemented by a license agreement by and between 99 High Street Owner LLC and Praxis Precision Medicines, Inc. dated September 25, 2025” SEC filing
“The other in-licensed patent family is owned by Ionis Pharmaceuticals, Inc., and is directed to compositions of matter of elsunersen.” SEC filing
“On September 11, 2019, the Company entered into both a Cooperation and License Agreement (the "License Agreement") with RogCon, Inc. ("RogCon"), and a Research, Collaboration, Option and License Agreement (the "Ionis Collaboration Agreement") with Ionis Pharmaceuticals, Inc. ("Ionis").” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.